Locations:
Search IconSearch
September 13, 2021/News Updates

Visitation Guideline Changes at Cleveland Clinic Ohio Locations

September 13, 2021

Main Aerial-04

The safety of our patients, visitors and caregivers remains our top priority. As cases of COVID-19 have been increasing over the past few weeks, we are experiencing a significant number of patients with COVID-19 in our hospitals. Therefore, beginning Tuesday, September 14, our visitation policy for our Ohio locations will include increased restrictions.

For patients who are either COVID-19 positive or negative, the changes include:

  • Inpatients will be allowed one designated visitor through their entire hospital stay.
  • Outpatients will be allowed one visitor per appointment or procedure.
  • Patients in the Emergency Department will be allowed one designated visitor through their entire hospital stay.

Note these additional changes:

  • During prenatal appointments:
    • Patients who are COVID-19 positive will be allowed one visitor.
    • Patients who are COVID-19 negative will be allowed two visitors for fetal ultrasounds and one visitor for regular prenatal appointments.
  • In Labor and Delivery:
    • Patients who are COVID-19 positive will be allowed one visitor during labor.
    • Patients who are COVID-19 negative will be allowed two visitors.
  • In pediatrics:
    • Patients who are COVID-19 positive will be allowed one parent or guardian.
    • Patients who are COVID-19 negative will be allowed two parents or guardians.

Visitation hours remain 7am -9 pm. All visitors must be at least 18 years of age, wear a mask at all times, and pass a COVID health screening upon arrival.

The most up to date information on our visitation policies can be found on our website at clevelandclinic.org/visitation.

Latest from the Newsroom

Beri Ridgeway, M.D.

Cleveland Clinic Appoints Beri Ridgeway, M.D., as President of Cleveland Clinic London

Genediting Therapy Shows Success Against Severe Sickle Cell Disease

Gene Editing Therapy Shows Success Against Severe Sickle Cell Disease

Cleveland Clinic's Main Campus lobby

Mandel Foundation Donates $50 Million to Improve Access to Care at Cleveland Clinic

Blood pressure cuff

Experimental Monthly Injectable Reduces a Key Regulator of Blood Pressure

GLP-1 injection pen with a stethoscope

Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease

Hospital Care At Home

Cleveland Clinic Introduces Hospital Care At Home in Ohio

Image of a scaled and tape measure

What Happens When Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic Study Reveals Real World Insights

Illustration of digital medical records

AI-Driven Chart Review Accurately Identifies Potential Rare Disease Trial Participants in New Study